Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 3 , Pages 271-274, April 2012

Activation of TrkB receptors by NGFβ mimetic peptide conjugated polymersome nanoparticles

  • Roy Soumen, Dr.rer.nat

      Affiliations

    • Department of Otolaryngology, Medical University of Innsbruck, Innsbruck, Austria
  • ,
  • A.H. Johnston, PhD

      Affiliations

    • School of Biological Sciences, University of Southampton, Southampton, United Kingdom
  • ,
  • Syed Tarique Moin, MSc

      Affiliations

    • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan
  • ,
  • Jozsef Dudas, PhD

      Affiliations

    • Department of Otolaryngology, Medical University of Innsbruck, Innsbruck, Austria
  • ,
  • T.A. Newman, PhD

      Affiliations

    • School of Medicine, University of Southampton, Southampton, United Kingdom
  • ,
  • Barbara Hausott, PhD

      Affiliations

    • Division of Neuroanatomy, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • Anneliese Schrott-Fischer, PhD

      Affiliations

    • Department of Otolaryngology, Medical University of Innsbruck, Innsbruck, Austria
    • Corresponding Author InformationCorresponding author: Department of Otolaryngology, Medical University of Innsbruck, Inner Ear Research Laboratory, 6020 Innsbruck, Austria.
  • ,
  • Rudolf Glueckert, PhD

      Affiliations

    • Department of Otolaryngology, Medical University of Innsbruck, Innsbruck, Austria

Received 10 June 2011; accepted 16 December 2011. published online 28 December 2011.

Abstract 

Activation of tyrosine kinase receptor B (TrkB), a neurotrophin receptor, has been shown to increase neuronal cell survival and promote regeneration. Stimulation of the TrkB receptor by neurotrophic growth factors has been identified as a possible therapeutic target for the treatment of neurodegenerative disorders. However, growth factor delivery is problematic because of a short half-life in vivo. We have conjugated hNgf-EE, a short peptide mimetic of NGFβ to the surface of polymersome nanoparticles and shown that they are capable of activating the TrkB receptor in vitro in the SHSY-G7 cell line. We propose that polymersomes could act as a scaffold for the delivery of TrkB activating moieties and that the polymersome size and polyethylene glycol surface have been shown to increase in vivo retention time. These multifunctional nanoparticles have potential for the treatment of neurodegenerative disorders by TrkB activation.

From the Clinical Editor

Tyrosine kinase receptor B activation has been shown to promote regeneration and survival of neurons. However, growth factor delivery to stimulate these receptors remains problematic. The authors demonstrate that a peptide mimetic of NGFβ conjugated to the surface of polymersome nanoparticles is capable of activating the TrkB receptors. These nanoparticles may offer a novel treatment strategy for a variety of neurodegenerative disorders.

Graphical Abstract 

TrkB activation by hNgf EE conjugated polymersomes. The graphical abstract shows activation of TrkB receptors by polymesome supported hNgf EE peptides. Phosphorylation of TrkB receptors lead to stimulation of the MAPK/ERK, PLCγ and PI3K signaling pathway which promote cell survival.

Key words: Nanoparticle based receptor targeting, Polymersomes, SHSY cells, Trk B activation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No conflict of interest was reported by the authors of this paper.

 This research was supported by European Community. Grant number: NMP4-CT-2006-026556 Integrated EU project.

PII: S1549-9634(11)00655-1

doi:10.1016/j.nano.2011.12.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 3 , Pages 271-274, April 2012